|Registered and Head Office:||Clinical Sciences Building
Nottingham NG5 1PB
|Company Secretary:||Andrew Millet
|Nominated Adviser and Broker:||Zeus Capital Limited
41 Conduit Street
London W1S 2YQ
82 King Street
Manchester M2 4WQ
|Reporting Accountants:||Grant Thornton UK LLP
101 Cambridge Science Park
Cambridge CB4 0FY
|Solicitors to the Company:||Peachey & Co LLP
London WC2B 4JF
|Patent Attorneys to the Company:||Boult Wade Tennant
70 Gray’s Inn Road
London WC1X 8BT
|Legal advisers to the Nominated Adviser and Broker:||K&L Gates LLP
One New Change
London EC4M 9AF
|Financial PR:||Consilium Strategic Communications Limited
London EC2R 7HG
|Company Registrars:||Capita Asset Services Limited
34 Beckenham Road
Kent BR3 4TU
Electronic versions of the materials you are seeking to access are being made available on this website by Oncimmune Holdings plc (the “Company”).
These materials are not directed to nor are they intended for access by persons located or resident in the United States, Australia, Canada, South Africa, Japan or any other jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction.
None of the securities of Company discussed or referred to in the materials you are seeking to access have been registered under the US Securities Act or 1933, as amended (the “Securities Act”) and may not be offered, sold, pledged or otherwise transferred except (1) in an offshore transaction meeting the requirements of Rule 903 or Rule 904 of Regulation S under the Securities Act, (2) pursuant to an effective registration statement under the Securities Act, or (3) pursuant to an available exemption from the registration requirements of the Securities Act, in each case in accordance with all applicable securities laws.
By clicking the “SUBMIT” button below you confirm that you (1) have read and understood the information set out above, (2) agree to be bound by its terms, (3) are not located in the United States and do not have a registered address in, and are not resident or located in, Australia, Canada, South Africa or Japan and (4) are permitted under applicable law and regulation to proceed to the following parts of this website.